Skip to content

Evaluation of umbilical cord blood drivated stem cells and Pistacia atlantica reasin extract effect and comparison of effectiveness between them

Evaluation of umbilical cord blood drivated stem cells and Pistacia atlantica reasin extract effect and comparison of effectiveness between them

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20241210064018N1
Enrollment
30
Registered
2025-05-21
Start date
2025-06-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: 2nd degree burn wound. Condition 2: 3rd degree burn wound.

Interventions

Intervention 1: Control group: For control group patients, wound dressing and washing will be done daily.Daily dressings will be applied with silver sulfadiazine cream and sterile Vaseline gauze, and

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 60 Years

Inclusion criteria

Inclusion criteria: Both male and female patients with 2nd and 3rd degree burns will be included in the study.

Exclusion criteria

Exclusion criteria: Unwillingness to cooperate and defects in entry criteria Community Verified icon The existence of an underlying disease including chronic diseases such as heart diseases, liver or renal impairment, diabetes mellitus and obesity Age below 15 years or above 60 years. Presence of respiratory injury or old wound (more than 2 weeks). Burn wounds caused by radiation, electrocution and chemical.

Design outcomes

Primary

MeasureTime frame
Patient body temperature. Timepoint: in day 1- 7- 14- 30- 60. Method of measurement: celsius degree.;Vascular endothelial growth factor. Timepoint: in day 1- 7- 14- 30- 60. Method of measurement: blood sample.;C reactive protein. Timepoint: in day 1- 7- 14- 30- 60. Method of measurement: blood sample.;Wound contraction. Timepoint: in day 1- 7- 14- 30- 60. Method of measurement: wound area [day 1]-wound area [day x]/wound area [day 1]×100.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactArezou Pezhman

Zahedan University of Medical Sciences

arezou_pejman@yahoo.com+98 54 3329 1618

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026